Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_assertion description "[This work suggests that multilevel inhibition of the PI3K/Akt/mTOR pathway and double-block of cell cycle progression are effective strategies for DLBCL therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_assertion evidence source_evidence_literature NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_assertion SIO_000772 19223503 NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_assertion wasDerivedFrom befree-20140225 NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_assertion wasGeneratedBy ECO_0000203 NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP626747.RAfGt2J69em7VmBnv-MVrlIhgqJ-Td5lX5RO1ieqPPEG8130_provenance.